ConductScience.org, home

Paper39722883

Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics.

Zhu J and 7 others. ACS Catal, 2024. Cited by 8 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics. Papers, record 39722883. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39722883

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Catalytic Mechanism of SARS-CoV-2 3-Chymotrypsin-Like Protease as Determined by Steady-State and Pre-Steady-State Kinetics.
PubMed
Journal
ACS Catal
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.36, provisional
iCite
Revised in PubMed
2025-02-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhu JJiyunhttps://orcid.org/0000-0002-8861-5450
2Kemp AMAlexandria M
3Chenna BCBala Chttps://orcid.org/0000-0002-2660-5302
4Kumar VVivek
5Rademacher AAndrew
6Yun SSangho
7Laganowsky AArthurhttps://orcid.org/0000-0001-5012-5547
8Meek TDThomas Dhttps://orcid.org/0000-0002-1931-8073

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 AI166624NIAID NIH HHSUnited StatesR21AI166624PubMed

Source NIH RePORTER

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132792043COVID-19 Compared to Other Pandemic Diseases.Rambam Maimonides Med J2020https://conductscience.org/library/papers/32792043PubMed
234804549Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography.IUCrJ2021https://conductscience.org/library/papers/34804549PubMed
316350889Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists.Methods Biochem Anal2005https://conductscience.org/library/papers/16350889PubMed
43281418The behavior and significance of slow-binding enzyme inhibitors.Adv Enzymol Relat Areas Mol Biol1988https://conductscience.org/library/papers/3281418PubMed
525799115Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles.Anal Chem2015https://conductscience.org/library/papers/25799115PubMed
61883831Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism.Biochemistry1991https://conductscience.org/library/papers/1883831PubMed
74426388Mercaptide-imidazolium ion-pair: the reactive nucleophile in papain catalysis.FEBS Lett1974https://conductscience.org/library/papers/4426388PubMed
86696439Kinetic studies of the reactions catalyzed by glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides: pH variation of kinetic parameters.Arch Biochem Biophys1984https://conductscience.org/library/papers/6696439PubMed
97371835Solvent isotope effects on tautomerization equilibria of papain and model thiolamines.FEBS Lett1980https://conductscience.org/library/papers/7371835PubMed
1029336553Catalytic Mechanism of Cruzain from Trypanosoma cruzi As Determined from Solvent Kinetic Isotope Effects of Steady-State and Pre-Steady-State Kinetics.Biochemistry2018https://conductscience.org/library/papers/29336553PubMed
1136351451Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir.Nature2023https://conductscience.org/library/papers/36351451PubMed
1234288674Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases.J Med Chem2021https://conductscience.org/library/papers/34288674PubMed
1325196915Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease.Biochemistry2014https://conductscience.org/library/papers/25196915PubMed
1418656960Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects.Biochemistry2008https://conductscience.org/library/papers/18656960PubMed
1521524Determining the chemical mechanisms of enzyme-catalyzed reactions by kinetic studies.Adv Enzymol Relat Areas Mol Biol1977https://conductscience.org/library/papers/21524PubMed
1623471109Mass spectrometry of intact membrane protein complexes.Nat Protoc2013https://conductscience.org/library/papers/23471109PubMed
177176924Buffers of constant ionic strength for studying pH-dependent processes.Methods Enzymol1982https://conductscience.org/library/papers/7176924PubMed
1831361135Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?J Med Chem2019https://conductscience.org/library/papers/31361135PubMed
1919688822Challenging a paradigm: theoretical calculations of the protonation state of the Cys25-His159 catalytic diad in free papain.Proteins2009https://conductscience.org/library/papers/19688822PubMed
2018237196Steady-state and pre-steady-state kinetic evaluation of severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro cysteine protease: development of an ion-pair model for catalysis.Biochemistry2008https://conductscience.org/library/papers/18237196PubMed

See all 47 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
42599674Heat Shock Protein Inhibitor Tanespimycin (17AAG) Suppresses SARS-CoV-2 Main Protease Activity and Is More Potent Than Clinically Approved Antiviral Nirmatrelvir.Chembiochem2026https://conductscience.org/library/papers/42599674PubMed
41656622Environmental Contributions to Proton Sharing in Protein Low-Barrier Hydrogen Bonds.Biochemistry2026https://conductscience.org/library/papers/41656622PubMed
41279124Environmental Contributions to Proton Sharing in Protein Low-Barrier Hydrogen Bonds.bioRxiv2025https://conductscience.org/library/papers/41279124PubMed
41231215The energy landscape of N-ribosidic bond cleavage catalysed by 2'-deoxynucleoside 5'-phosphate N-hydrolase 1.Biochem J2025https://conductscience.org/library/papers/41231215PubMed
40837376Kinetic Dissection of the Reaction of Human GDP-l-Fucose Synthase.ACS Catal2025https://conductscience.org/library/papers/40837376PubMed
40618193Enzyme kinetics model for the coronavirus main protease including dimerization and ligand binding.Biophys J2025https://conductscience.org/library/papers/40618193PubMed
39746101Dual Inhibitors of SARS-CoV-2 3CL Protease and Human Cathepsin L Containing Glutamine Isosteres Are Anti-CoV-2 Agents.J Am Chem Soc2025https://conductscience.org/library/papers/39746101PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39722883

GET https://conductscience.org/api/papers/v1/39722883/references?page=2